Clinical trial
Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic…
NCT00271284 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00271284 |
|---|---|
| Title | Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients |
| Official title | A Crossover, Multicentre, Randomised Trial Comparing the Effect on the Control of Blood Glucose Concentration of Insulin Glargine and Insulin Detemir, Combined With Insulin Glulisine, Used as a Bolus, in Type 1 Diabetic Patients |
| Acronym | VARIABILITE |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin glulisine / insulin glargine, insulin glulisin / insulin detemir |
| Enrollment | 88 |
| Start date | Oct 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Dec 30, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: